TOLFEDINE TABLETS 6 MG

Country: Malaysia

Language: English

Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Active ingredient:

TOLFENAMIC ACID

Available from:

Gladron Chemicals Sdn Bhd

INN (International Name):

TOLFENAMIC ACID

Units in package:

16.00 mcg/mL; 20.00 mcg/mL

Manufactured by:

Vetoquinol

Summary of Product characteristics

USER WARNINGS
In case of accidental contact with eyes, wash with plenty of water.
TO BE SUPPLIED ONLY ON VETERINARY PRESCRIPTION
KEEP OUT OF REACH OF CHILDREN / JAUHI DARIPADA KANAK-KANAK
STORE IN A DRY PLACE - DO NOT STORE ABOVE 25° C
KEEP BLISTER STRIPS IN OUTER CARTON
MANUFACTURED BY:
VETOQUINOL
Magny Vernois
70200 Lure (France)
To be supplied only on veterinary prescription
REGISTRATION HOLDER:
Gladron Chemicals Sdn. Bhd.
No.7, Jalan TP7,
UEP Industrial Park,
40400 Shah Alam,
Selangor Darul Ehsan.
Dispose of used packaging in the household refuse.
Unused product should be returned to the veterinary surgeon.
FOR ANIMAL TREATMENT ONLY
_VETERINARY PHARMACEUTICALS_
70200 LURE (France)
TOLFEDINE
®
TABLETS 6 MG
NON STEROIDAL ANTI-INFLAMMATORY - ANALGESIC - ANTIPYRETIC
Each tablet contains: 6mg tolfenamic acid active ingredient
White convex tablets with average mass of 0.08g
Tablets are packed in PVC/Aluminium blisters.
Box of 16 tablets (2 blisters of 8 tablets)
Box of 20 tablets (2 blisters of 10 tablets)
INDICATIONS
Cats: In febrile syndrome (abscess, fever of unknown origin)
Dogs:
Treatment for alleviation of acute episodes of inflammation and
pain in chronic locomotor disease
_DIMENSIONS : 160x120 mm pliée_
_RÉFÉRENCE ARTICLE : 0611 B_
_NOM DU PRODUIT :_
_Notice Tolfédine 6mg MALAISIE_
_1 COULEUR_
_281 U_
_CRÉÉ PAR : V.massard_
_LE : _
_VISA :_
_REV B_
_VÉTOQUINOL _
PHARMACODYNAMIC PROPERTIES
Tolfenamic
acid
(N‑(2‑methyl‑3‑chlorophenyl)
anthranilic
acid)
is
a
non-steroidal anti-inflammatory drug belonging to the fenamate group.
Tolfenamic acid possesses anti-inflammatory, analgesic and antipyretic
properties.
The anti-inflammatory activity of tolfenamic acid is especially due to
an
inhibition of cyclooxygenase leading to a reduction of prostaglandin
synthesis and thromboxanes, major inflammatory mediators.
PHARMACOKINETIC PROPERTIES:
ABSORPTION :
IN THE DOG,
tolfenamic acid is rapidly absorbed. After a single oral
administration of 4mg/kg tolfenamic acid, the mean maximal plasma
concentration (